Home>>Signaling Pathways>> GPCR/G protein>> RGS Protein>>CCG 2046

CCG 2046 Sale

目录号 : GC16137

CCG 2046 是一种 RGS4 抑制剂,IC50 为 4.3 μM 针对 RGS4-Gαo 相互作用信号。

CCG 2046 Chemical Structure

Cas No.:13017-69-1

规格 价格 库存 购买数量
10mg
¥2,279.00
现货
50mg
¥9,629.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

产品描述

CCG 2046 is an inhibitor of TNF-α with IC50 values of 2.32 µM and 0.66 µM in the HTRF assay and the ELISA assay, respectively [1]. CCG 2046 is also an inhibitor of RGS4.

Three members of tumor necrosis factor (TNF) family are: TNF-α, TNF-β (also called lymphotoxin α, LT-α) and LT-β. Tumor necrosis factor-α (TNF-α) is a secreted cytokine. It plays an important role in immune disorders and inflammatory diseases. TNF-α is also involved in the inhibition of viral replication and in some cases of programmed cell death. At the cellular level, TNF-α can regulate multiple signaling pathways, such as NF-kB activation and apoptosis [1].

Both LPS and TNF-α can downregulate RGS4 [2]. CCG 2046 reduced the RGS4-Gα0 interaction signal with an IC50 value of 4.3 ± 0.2 µM [3]. Infliximab is also a TNF-α inhibitor [4]. IL-10 mRNA was upregulated by 2.6 folds after stimulating mTNF using rabbit antihuman TNF-α polyclonal Ab for 6 hours. WT mTNF-transfected Jurkat cells incubated with infliximab at 10 µg/mL for 24 hours also showed a 2.7-fold increase in the production of IL-10 with statistical significance. These results were indicated by cDNA expression array analysis [5].

Infliximab is described hereafter. 1 h after the infusion with infliximab, concentrations of serum TNF-α protein in a subset of patients were significantly reduced. At 24 and 48 h following the first dose of infliximab, patients showed a significantly declined CCL2 concentration [4]. TNF-α was suggested to promote the expression of CCL2 by tumor cells [6].

References:
[1].  Leister KP, Huang R, Goodwin BL, et al. Two high throughput screen assays for measurement of TNF-α in THP-1 cells. Current chemical genomics, 2011, 5(1): 21-29.
[2].  Magder S, Neculcea J, Neculcea V, et al. Lipopolysaccharide and TNF-α produce very similar changes in gene expression in human endothelial cells. Journal of vascular research, 2006, 43(5): 447-461.
[3].  Roman DL, Talbot JN, Roof RA, et al. Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay. Molecular pharmacology, 2007, 71(1): 169-175.
[4].  Brown ER, Charles KA, Hoare SA, et al. A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer. Annals of oncology, 2008, 19(7): 1340-1346.
[5].  Mitoma H, Horiuchi T, Hatta N, et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-α. Gastroenterology, 2005, 128(2): 376-392.
[6].  Ben-Baruch A. Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Research, 2003, 5(1): 31-36.

Chemical Properties

Cas No. 13017-69-1 SDF
化学名 3-methyl-3-propylcyclopropane-1,1,2,2-tetracarbonitrile
Canonical SMILES N#CC1(C#N)C(CCC)(C)C1(C#N)C#N
分子式 C11H10N4 分子量 198.22
溶解度 <19.82mg/ml in DMSO 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 5.0449 mL 25.2245 mL 50.449 mL
5 mM 1.009 mL 5.0449 mL 10.0898 mL
10 mM 0.5045 mL 2.5224 mL 5.0449 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置